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The effect of HIV infection on time off work in a large
cohort of gold miners with known dates
of seroconversion
Pam Sonnenberg,1 Andrew Copas,1 Judith R Glynn,2 Andre Bester,3 Gill Nelson,4,5
Stuart Shearer,3 Jill Murray4,5
ABSTRACT
Objectives To estimate the effect of HIV infection on
time off work. To provide baseline estimates for
economic and actuarial models, and for evaluations of
ART and other workplace interventions.
Methods A retrospective cohort study of gold miners
with known dates of seroconversion to HIV, and an HIV-
negative comparison group, used routinely collected data
to estimate the proportion of time off work by calendar
period (1992e2002, prior to the introduction of ART),
age, time since seroconversion and period before death.
The authors calculated ORs for overall time off work and
RR ratios (RRR, using multinomial logistic regression) for
reasons off work relative to being at work.
Results 1703 HIV-positive and 4859 HIV-negative men
were followed for 34 424 person-years. HIV-positive
miners spent a higher proportion of time off work than
negative miners (20.7% vs 16.1%) due to greater
medical and unauthorised absence. Compared with HIV-
negative miners, overall time off work increased in the
first 2 years after seroconversion (adjusted OR 1.40
(95% CI 1.36 to 1.45)) and then remained broadly stable
for a number years, reaching 38.8% in the final year
before death (adjusted OR 3.27, 95% CI 2.95 to 3.63).
Absence for medical reasons showed the strongest link
to HIV infection, increasing from an adjusted RRR of 2.66
(95% CI 2.45 to 2.90) for the first 2 years since
seroconversion to 13.6 (95% CI 11.8 to 15.6) in the year
prior to death.
Conclusions Time off work provides a quantifiable
measure of the effect of HIV on overall morbidity. HIV/
AIDS affects both labour supply (increased time off work)
and demand for health services (increased medical
absence). The effects occur soon after seroconversion
and stabilise before reaching very high levels in the
period prior to death. Occupational health services are an
important setting to identify HIV-infected men early.
INTRODUCTION
The impact of the HIV/AIDS epidemic on workers,
industry, economies and society is substantial, since
HIV affects individuals in their productive working
years of life. The consequences are most profound
for labour-intensive industries (eg, mining and
construction) which are also the sectors with the
highest HIV prevalences in southern Africa.1 It is
estimated that HIV prevalence on the South
African gold mines was 1.3% in 1990,2 rising to
20e30% by 1998.3 4
Economic and actuarial models of the projected
impacts of HIV/AIDS5e7 and the cost-effectiveness
of interventions, including treatment,8 require
robust estimates of model parameters. There is,
however, a paucity of published work, based on
empirical data, on the impact of HIV/AIDS on time
off work.9e14 Existing studies are limited in that
they are often based on relatively small numbers
with short follow-up, lack an HIV-negative
comparison group or use self-reported outcomes,
and none have used seroconverter cohorts. Baseline
data, prior to the introduction of antiretroviral
therapy (ART), are needed to assess and model the
current and future impact of HIV in the working
population and for the design and evaluation of
appropriate interventions.
This large cohort study of gold miners with
known dates of seroconversion and an HIV-nega-
tive comparison group, estimates the effect of HIV/
AIDS and duration of infection on supply of labour
(measured as time off work) and demand for health
services (measured as time off work for medical
reasons) prior to the rollout of ART.
The natural history of HIV has been extensively
studied using clinical events, such as time to AIDS,
or death as endpoints.15 We have previously esti-
mated the effect of HIV on mortality,16 tubercu-
losis17 and work-related injuries.18 The impact of
HIV on overall functioning and morbidity, espe-
cially in the early period following seroconversion,
has not been described. This study therefore also
provides a unique opportunity to estimate the
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impact of HIV/AIDS and how this changes by duration of
infection using a quantiﬁable measure of morbidity.
METHODS
A retrospective cohort study was conducted among men
working on four goldmines in South Africa, using routinely
collected data. Free medical services are provided by the mine
company, with ART introduced in 2004. Details of the study
design have been published.16e18 Brieﬂy, HIV tests were done
with counselling and consent in two surveys in 1992e1993, in
sexually transmitted disease clinics, and as clinically indicated,
and results kept on a single conﬁdential database. Individuals
who were HIV-negative in one of the surveys and had no later
evidence of HIV from tests or clinical diagnoses form the HIV-
negative comparison group. The HIV seroconverter cohort is
formed from individuals with an HIV-negative test and
a subsequent HIV-positive test in either of the surveys or from
testing done in clinics or the hospital (excluding tests done on
medical or tuberculosis wards) until 1998. Consequently, the
HIV-negative cohort was recruited in 1992e1993, with the
seroconverters recruited in 1992e1998. We restricted the sero-
converter cohort to individuals with intervals of less than
3 years between the last negative and ﬁrst positive test. The
seroconversion date was taken as the midpoint of the serocon-
version interval. The study was approved by Ethics Committees
at the University of the Witwatersrand, South Africa and
LSHTM, UK.
The mine maintains a number of human resources system
(HRS) databases, which include demographic information,
employment history, payroll and time off work. The format of
the routinely available datasets did not include time at work. We
accessed an active database on currently employed men, as well
as archived data on men who had left the mine. Records
between 1 August 1992 and 1 October 2002 were available. In
general, miners work 312 shifts per year, with up to 56 days
leave (half of which is paid leave). In this context, ‘at work’
refers to doing routine activity (includes work, training, allo-
cated rest days). For every employee, a record is entered for each
episode off work, based on the dates of the ﬁrst and last shifts
missed. Reasons for being off work were grouped into medical,
leave (annual, compassionate and unpaid leave) and unau-
thorised absence (including absence for an unknown reason).
The HIV and HRS databases were linked using unique industry
numbers. For construction of the cohort, HIV-negative men
entered the analysis at the time of the negative test in the
survey. HIV-positive men entered at the estimated date of
seroconversion. Follow-up continued until the miner left the
mine or died, or 1 October 2002.
We determined the proportion of time off work overall and by
reason, with the overall number of days of follow-up as the
denominator. We estimated the effect of HIV status on time off
work compared with HIV-negative miners, with age, duration of
HIV infection and calendar period as time-varying covariates. We
calculated ORs using logistic regression for overall time off
work. To investigate associations with each type of time off
work, we assign time as either at work or in each of three types
of time off. We then use multinomial logistic regression to
simultaneously model the probabilities of time being spent in
each of these four outcome categories. This regression generates
RR ratios (RRR) for each type of time off relative to being at
work. For each predictor, the RRR is the ratio of the RR for the
type of time off to the RR for being at work, which corresponds
to the OR ignoring the other types of time off.
To determine the effect of end-stage HIVon time off work and
reason, independent of time since seroconversion, we estimated
the time off in the 2 years prior to death in those who died from
natural causes, using data on date and cause of death collected as
part of our larger study.16 19 We compared HIV-positive men
prior to death with HIV-negative men (overall and restricted to
those who died).
Since days at work were not recorded, to assess completeness
of the time off dataset, we identiﬁed gaps (no record of time off)
of greater than 12 months and their relationship to study entry
dates. In light of our ﬁndings (see Results), our primary analysis
includes follow-up from the date of the ﬁrst record in the time
off database. To address a possible bias resulting from beginning
follow-up at the ﬁrst record of time off, we repeated the main
analysis with subjects entering on the date of entry to the
cohort. As a sensitivity analysis, we repeated the main analysis
using the period before seroconversion as the baseline in the
subgroup of miners with time off work records before and after
seroconversion.
RESULTS
Individuals included in the analysis
A total of 1950 HIV-positive and 5814 HIV-negative miners were
eligible for this study. Our initial analysis was based on the 1703
(87%) HIV-positive and 4859 (84%) HIV-negative men for
whom records of time off work were available (table 1). Those
miners with records available were younger, recruited later, more
likely to be still employed in 2002 and more likely to be HIV-
positive, and had longer study follow-up than those miners
without records of time off work. When this comparison of
miners included and excluded from our analysis was made
separately for HIV-positive and -negative miners, the same
differences were found, except that among HIV-negative miners
there was no difference in the year of study recruitment (data
not shown).
Calculation of follow-up time
The overall study follow-up included a total of 39 781 person
years. However, long gaps (no record of time off for $12
months) make up 2538 person years in HIV-negative (8.1% of
total) and 1101 (13.1%) in HIV-positive miners. These gaps are
primarily at the start of study follow-up. Consequently, for our
primary analyses, subjects entered follow-up at the date of the
ﬁrst documented period off work. This reduced the time repre-
sented by long gaps to only 296.0 person years (1.1%) and 57.0
(0.9%) in HIV-positive and HIV-negative men, respectively.
Proportion of time off work by HIV status, calendar period, age
and time since seroconversion
Table 2 shows that, overall, 83.0% of follow-up time was at
work, with miners being off work due to leave (13.1% of time),
for medical reasons (2.7%) and unauthorised absence (1.3%). In
absolute terms, on average, HIV-negative miners are at work for
307 days per year and off sick for 8 days. In contrast, the
respective numbers of days in HIV-positive miners are 290 and
20. Unauthorised absence declined with increasing age and over
calendar period. HIV-positive miners spent more time off work
than HIV-negative miners (20.7% vs 16.1%).
Comparison of HIV-positive and HIV-negative miners who died
Among 361 HIV-positive miners who died from natural causes
(table 3), 23.7% of time in the penultimate year was spent off
work, rising to 38.8% in the ﬁnal year, a high proportion of
which was for medical reasons. The average number of days at
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work in the ﬁnal year of life had decreased to 224, with the time
off due to medical reasons increasing to 80 days. Table 3 also
shows that the 167 HIV-negative miners who died from natural
causes spent 27.8% of time off work in the ﬁnal year of life
(264 days), 13.2% (48 days) of which were for medical reasons.
After adjustment for age and calendar period, the overall time off
in the ﬁnal year was higher in the 361 HIV-positive miners who
died (OR 1.70; 1.35 to 2.15) and this increase was primarily due
to medical absence (RRR 2.05; 1.42 to 2.97).
Figure 1 shows that, in HIV-positive miners, after an initial
increase in time off work, compared with HIV-negative men, the
overall proportion remained broadly stable for a number of
years, then rose in the 2 years prior to death. Medical leave
follows a similar pattern, but with a gradual increase over the
8-year period, and dramatic rise in the ﬁnal year.
Effect of HIV infection by time since seroconversion, adjusting
for age and calendar period
In the adjusted analysis (table 4), overall absence from work,
relative to HIV-negative miners, increased in the 2 years after
seroconversion (adjusted OR 1.40, 95% CI 1.36 to 1.45) and
remained at this increased odds for some years, rising to an OR
of 3.27 (2.95 to 3.63) in the year before death. Medical absence
shows the strongest link to HIV infection and time since sero-
conversion, with adjusted RRR relative to being at work and
relative to HIV-negative miners of 2.66 (2.45 to 2.90) for the ﬁrst
2 years after seroconversion, increasing gradually over time and
reaching 13.6 (11.8 to 15.6) in the year prior to death. Although
the crude proportion of time off due to unauthorised absence
decreased with time since seroconversion, this was confounded
by calendar period, and after adjustment, unauthorised absence
Table 2 Descriptive analysis of the proportion of time at and off work
Off work (%)
Total, (person-years)Factor At work (%) Medical Leave Unauthorised absence
Total 83.0 2.7 13.1 1.3 34 424
HIV status
Positive 79.3 5.5 13.4 1.9 6643
Negative 83.9 2.1 13.0 1.1 27 781
Calendar period
1992e1995 84.3 1.7 12.3 1.7 7080
1995e1996 81.9 2.5 14.0 1.7 8764
1997e1998 82.1 3.6 13.2 1.1 8206
1999e2000 83.7 2.8 12.7 0.8 6019
2001e2002 83.7 3.1 12.8 0.5 4354
Age (years)
<30 82.9 2.6 12.6 2.0 5237
30e39 83.2 2.6 13.0 1.2 17 539
40+ 82.7 2.9 13.4 1.0 11 648
No of years since HIV seroconversion
<2 78.5 4.8 14.2 2.6 1927
2 to <4 79.5 5.2 13.3 2.0 1972
4 to <6 79.6 6.0 12.9 1.5 1532
6 to <8 79.9 5.9 13.0 1.2 857
8+ 79.3 7.1 12.6 1.0 355
Table 1 Comparison of miners by inclusion in the analysis and by HIV status
Included in analysis No records of
time off
Factor
HIV-positive HIV-negative Total
n % n % p Value* n % n % p Valuey
Total 1703 4859 6562 1202
Age (years) at start of study <0.001 <0.001
15e24 264 15.5 555 11.4 819 12.5 117 9.7
25e34 966 56.7 2466 50.8 3432 52.3 475 39.6
35e44 395 23.2 1433 29.5 1828 27.9 257 21.4
45+ 78 4.6 405 8.3 483 7.4 352 29.3
South African 835 49.0 2523 51.9 0.04 3358 51.2 636 53.0 0.26
Calendar year of study recruitment <0.001 <0.001
#1992 426 25.0 1816 37.4 2242 34.2 450 37.4
1993 338 19.9 3043 62.6 3381 51.5 634 52.8
1994+ 939 55.1 0 0 939 14.3 118 9.8
Still employed in 2002 444 26.1 1855 38.2 <0.001 2299 35.0 110 9.2 <0.001
HIV-positive e e 1703 26.0 247 20.6 <0.001
Median (IQR) study follow-up, years 4.9 (2.5 to 7.0) 6.6 (4.0 to 9.4) <0.001 6.0 (3.3 to 9.3) 4.8 (2.5 to 5.9) <0.001
Median (IQR) follow-up, years
(primary analysis)
3.4 (1.9 to 5.6) 5.4 (3.2 to 9.3) <0.001 5.0 (2.5 to 8.7)
*p Value from test comparing HIV-positive and HIV-negative miners.
yp Value from test comparing those included and excluded from the analysis.
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was greater in HIV-positive men, with an RRR of 1.95 (1.84 to
2.06) in the ﬁrst 2 years, increasing to 3.75 (3.15 to 4.46) in the
ﬁnal year before death. In contrast, authorised leave was only
modestly elevated in HIV-positive miners and demonstrated
little association with time since seroconversion; the greatest
adjusted RRR for authorised leave was 1.51 (1.31 to 1.73) seen in
the year prior to death.
Repeating the analysis based on commencing follow-up time
at study entry rather than at the start of records of time off
work increased the time spent at work, so that the percentage of
time off work for medical reasons, leave and unauthorised
absence was reduced to 4.3%, 10.6% and 1.5% in HIV-positive
miners and 1.8%, 11.5% and 1.0% in HIV-negative miners
respectively. The associations between HIV infection and work
absence were broadly unchanged, though with some reduction
in the apparent effect of HIV infection in the ﬁrst years
following seroconversion. The adjusted OR (95% CI) for time
off work relative to HIV-negative miners was 1.00 (0.95 to 1.04)
in the ﬁrst 2 years following seroconversion, increasing to 1.43
(1.32 to 1.56) at 8 years or more and reaching 3.43 (3.09 to 3.81)
in the year before death. Considering time off work for medical
reasons the adjusted RRR (95% CI) relative to being at work and
to HIV-negative miners was 1.95 (1.79 to 2.13) in the 2 years
following seroconversion increasing to 3.49 (2.88 to 4.24) at
8 years or more and reaching 14.2 (12.3 to 16.3) in the year
before death.
Time off work in HIV-positive men before and after
seroconversion
In this sensitivity analysis of 819 miners, overall time off work
increased after seroconversion from 17.6% to 19.8% in the ﬁrst
2 years (OR 1.16; 1.11 to 1.21). Medical absence increased from
2.4% preseroconversion to 4.1% in the ﬁrst 2 years (RRR 1.80;
1.59 to 2.03).
DISCUSSION
In this large study that followed a cohort of seroconverters and
an HIV-negative control group for up to 10 years, we found that
HIV-positive miners spent more time off work than HIV-nega-
tive miners, mainly due to greater medical absence. The
increased time off work was apparent soon after seroconversion,
rose with duration of HIV infection (albeit modestly in the ﬁrst
8 years) and reached very high levels in the later stages of
disease, with men being off work nearly 40% of the time in the
year prior to death. HIV/AIDS has a profound impact on both
the supply of labour and demand for medical care.
The study strengths include a large sample size, an HIV-
negative comparison group and a long follow-up. Linking to
mortality data and analysing time off in the years prior to death
also provide maximum estimates for the period when individ-
uals are likely to have AIDS. Unlike self-reported indicators of
health, with the potential for recall and response bias, time off
data are routinely collected. Furthermore, in contrast to settings
where sickness absence may be taken for reasons other than
illness, in the mines sick leave is granted only following a visit to
the health services.
The study may be limited by the incompleteness of the data
as represented in gaps in the dataset or a total absence of time
off records, although this was not directly linked to HIV status.
Repeating the analysis based on commencing follow-up time at
study entry rather than at the start of records of time off work,
we found more time spent at work for both HIV-positive and
HIV-negative miners, as expected, but broadly similar associa-
tions between work absence and HIV infection. Although we
were able to exclude those HIV-negative miners who we knew
had become HIV-positive, the HIV-negative comparison group is
likely to include undetected seroconverters, thus diluting the
effects we found. We recognise that the cohort includes
a different follow-up over calendar period and age for different
miners, but we control for these factors in the analysis, and
present the effect of HIV infection by time since seroconversion.
It is often the healthiest men who are recruited, and those
remaining in employment are ﬁt enough to endure strenuous
physical labour; the ‘healthy worker effect.’ The absolute
number of days off as a proxy for morbidity is therefore prob-
ably an underestimate, yet relative risks may be little affected.
HIV-positive workers may be inherent risk-takers before and
after infection. In our sensitivity analysis, we were able to
remove any such bias by using the preseroconversion period as
the baseline. The effects on time off work overall and medical
Table 3 Work attendance by HIV status and time period before death for 361 HIV-positive and 167 HIV-negative miners who died from natural causes
HIV-positive
(%) time, by years before death
HIV-negative
(%) time, by years before death Final year: adjustedz OR or RRR (95% CI)
HIV-positive versus HIV-negativeWork status >2 Penultimate Final >2 Penultimate Final
At work 78.4 76.3 61.2 81.9 76.2 72.2
Absent from work 21.6 23.7 38.8 18.1 23.8 27.8 1.70* (1.35 to 2.15)
Medical 5.7 8.6 21.8 3.6 7.5 13.2 2.05y (1.42 to 2.97)
Leave 13.4 13.2 14.4 12.9 14.7 12.8 1.34y (1.06 to 1.68)
Unauthorised 2.6 1.9 2.6 1.6 1.6 1.9 1.67y (1.19 to 2.34)
Total (person years) 669 220 191 369 85 90
*OR for work absence, HIV-positive versus HIV-negative.
yRR ratio for type of work absence relative to being at work, HIV-positive versus HIV-negative.
zAdjusted for age and calendar period.
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Figure 1 Proportion of time off work, by reason, HIV status, years
since seroconversion and years before death.
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absence were slightly reduced but remained signiﬁcant in the
ﬁrst 2 years following seroconversion.
By following a seroconverter cohort prospectively, as well as
looking retrospectively at the period before death, our study
quantiﬁes all-cause morbidity over the entire spectrum of HIV
disease. We have previously shown that the effect of HIV on
tuberculosis incidence17 and mortality16 occurs soon after
infection. Similarly, within the ﬁrst 2 years, HIV-positive men
are likely to have a larger proportion of time off work overall and
for medical reasons, suggesting early effects on overall morbidity.
In the terminal phase, comparing men who died from natural
causes, time off work was greater in the HIV-positive men than
in HIV-negative men, suggesting a more chronic decline. In this
setting, infectious causes of death predominated (88% of natural
deaths in HIV-positive and 41% in HIV-negative men), with
tuberculosis the leading cause of death in both groups.19
The implications of HIV on industry and the workforce are
multifaceted. With disease progression, and in the absence of
ART, HIV-positive workers are likely to have increasing time off
work, declining productivity and rising mortality. This study
does not provide data on productivity in the workplace, which is
difﬁcult to measure. Even if at work, HIV may be impacting on
productivity or on workplace organisation (so-called presen-
teeism), such as the delegation of less strenuous tasks13 or fellow
workers carrying the workload for those who are sick. Financial
incentives set a high threshold for taking time off. A study of 54
Kenyan tea estate workers who died or took medical retirement
found that HIV-positive workers plucked less tea per day (a
measure of work output), took more sick and annual leave, and
earned 18% less in their ﬁnal year.10 The results are an under-
estimate, since the HIV status of the comparison group was
unknown, and helpers were allowed to assist sick workers. The
impact on service delivery capacity may be more marked in the
public sector: the 45 HIV-positive employees of the Zambian
Wildlife Authority (ZAWA) who died had worked 68% less (63
vs 197 days) in their last year of service compared with in-service
employees.20 In the Swiss HIV Cohort Study,14 there were
substantial productivity losses, measured as ability to work and
monthly wages, and these were more likely in individuals with
worse clinical prognostic factors (older, longer duration of HIV,
lower CD4 count and a history of AIDS). Ability to work was
also dependent on other socio-economic factors that impact on
earning potential, such as gender, educational level and stable
partnerships.14 Similarly, we found that individuals who were
older or had longer durations of HIV infection had more time off
work.
HIV/AIDS results in higher worker turnover, loss of a skilled
labour force and an increased need for training. There is also
a loss of human capital: the experience and collectively acquired
knowledge of workers who die or leave employment.6 The effect
of supply shortages in the healthcare, public and educational
sectors, resulting from HIV infection in employees, is likely to
have even larger societal impacts. As early as 1990, the National
Railways of Zimbabwe reported operational problems due to
absenteeism of >15%.9 Furthermore, there is likely to be reduced
staff morale21 and changes in the status of men who had
previously been household breadwinners.22 HIV can be seen to
have even greater impacts on individuals, families and commu-
nities when one considers not only time off while in employ-
ment, but more broadly the years of productive life lost, which
includes time after leaving the mine for any reason, including
death. This theoretical time lost assumes that HIV-positive men
would have remained in healthy employment until retirement
age, rather than dying or becoming ill earlier, and recognises that
those who leave may be unlikely to gain employment elsewhere.
This study shows that HIV-positive individuals will require
increasing and substantial medical care, with implications for
the provision of health services both in the workplace and in
home areas. Relative to HIV-negative miners, time off for
medical reasons in those who are HIV-positive increased soon
after infection (RRR 2.7 in the ﬁrst 2 years) and reached 23% of
total time in the last year of life (RRR 13.6). A study in another
gold mine found a signiﬁcant difference in all-cause hospital-
isation rates between HIV-infected and non-infected employees,
2 years prior to death.4 Yet, hospitalisation only accounts for
a small proportion of days lost for medical reasons.12 HIV has
had a dramatic effect on the burden of tuberculosis, with both
a direct impact on incidence in HIV-positive individuals and
a secondary indirect increase in the HIV-negative population,23
which would further impact on demand for health services. HIV
also increases the risk of work-related injuries with implications
for medical care and compensation.18
This study, although conducted prior to the introduction of
ART, has important implications that are relevant currently, and
for the future. Despite the rollout of ART, the impact of HIV is
likely to continue, albeit on a smaller scale. Preliminary ﬁndings
from 59 HIV-positive Kenyan agricultural workers suggest that,
despite higher productivity in the ﬁrst year after starting ART,
Table 4 Effect of HIV on time off work, adjusted for calendar period and age
Factor Overall absence from work, OR Medical, RRRz Leave, RRRz Unauthorised, RRRz
HIV status and years since
seroconversion*
p<0.001 p<0.001 p<0.001 p<0.001
Negative 1 1 1 1
Positive (all years) 1.36 (1.33 to 1.39) 2.75 (2.58 to 2.94) 1.09 (1.07 to 1.11) 1.92 (1.84 to 2.01)
Positive: <2 1.40 (1.36 to 1.45) 2.66 (2.45 to 2.90) 1.16 (1.13 to 1.19) 1.95 (1.84 to 2.06)
Positive: 2 to <4 1.31 (1.27 to 1.35) 2.57 (2.35 to 2.81) 1.06 (1.03 to 1.10) 1.82 (1.70 to 1.93)
Positive: 4 to <6 1.35 (1.29 to 1.40) 2.81 (2.53 to 3.11) 1.06 (1.02 to 1.09) 1.96 (1.80 to 2.14)
Positive: 6 to <8 1.38 (1.31 to 1.46) 2.94 (2.54 to 3.41) 1.09 (1.04 to 1.13) 2.05 (1.83 to 2.30)
Positive: 8+ 1.45 (1.33 to 1.59) 3.56 (2.92 to 4.34) 1.06 (0.99 to 1.13) 2.33 (1.90 to 2.87)
HIV status and years before deathy p<0.001 p<0.001 p<0.001 p<0.001
Negative 1 1 1 1
Positive: >2 years before death 1.41 (1.34 to 1.49) 3.05 (2.62 to 3.56) 1.09 (1.05 to 1.14) 2.10 (1.90 to 2.32)
Positive: penultimate year 1.59 (1.45 to 1.73) 4.31 (3.62 to 5.13) 1.10 (1.01 to 1.20) 2.03 (1.75 to 2.35)
Positive: final year 3.27 (2.95 to 3.63) 13.6 (11.8 to 15.6) 1.51 (1.31 to 1.73) 3.75 (3.15 to 4.46)
*Adjusted OR and RR ratio (RRR) with 95% CI are from a regression model including calendar time, age and HIV status/years since seroconversion.
yAdjusted OR and RRR with 95% CI are from a regression model including calendar time, age and HIV status/years before death. All data from HIV-negative miners are used together with data
from those HIV-positive miners who died during follow-up from natural causes.
zRR ratio values with 95% CI are given relative to being at work.
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absenteeism and productivity may not return to HIV-negative
levels.11 A recent study in three South African clinics found that,
compared with pre-ART patients, those on ART reported less
functional impairment and better work performance; however,
there remained a high prevalence of some impairment, symp-
toms and absenteeism.24 Follow-up of similar cohorts to the one
in this study, including the period when ART is readily available,
will provide insights into the impact of treatment on time off
work and whether this is sustained over time.
Many HIV-infected individuals present to health services with
advanced immunosuppression, and this is higher in men.25
Occupational health services are an important setting in which
to identify HIV-infected men early. Occupational settings may
also have the infrastructure and expertise to provide HIV-
prevention campaigns, increased uptake of testing, wellness
clinics and early ART. In addition to the impact on industry and
the workforce, our ﬁndings suggest that HIV/AIDS will result in
a greater need for healthcare, with implications for health
services and resource allocation. Since the effects of HIV on
morbidity and mortality start soon after seroconversion, at
a time prior to the recommendation for commencement of ART,
even with an ART programme there will be an increased need for
healthcare overall, in addition to the implications of providing
lifelong ART.
Evaluations of interventions need to consider the effect on
delaying or averting HIV-related costs. A key element of any
workplace intervention would be a multisectoral approach
including workers, the private sector, communities and govern-
ment.26 Interventions need to consider a broader ‘combination
prevention’ approach that integrates behavioural, biomedical
and structural HIV-prevention strategies with HIV treatment.27
This study provides empirical data that can be used as a baseline
to estimate the cost-effectiveness of interventions and to
support the International Labour Organisation statement that
‘the direct and indirect costs of inaction are far greater than the
costs of treatment.’6
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